Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Encoded Therapeutics has Introduced ETX101 for the Treatment of Patients with Dravet Syndrome
Encoded Therapeutics has introduced ETX101 for the treatment of SCN1A+ Dravet syndrome, a rare and severe genetic neurological disorder that begins in early childhood....
Sanofi Introduces Breakthrough Rilzabrutinib for the Treatment of Warm Autoimmune Haemolytic Anaemia
Sanofi has introduced rilzabrutinib for the treatment of patients with warm autoimmune haemolytic anaemia (wAIHA), a rare autoimmune disorder characterised by the destruction of red blood cells....
Novartis Introduces Breakthrough Ianalumab for the Treatment of Sjögren’s Disease
Novartis has introduced ianalumab for the treatment of patients with Sjögren’s disease, a chronic autoimmune condition that affects the body’s moisture-producing glands and can involve multiple organs....
Protara Therapeutics Introduces Breakthrough TARA-002 for the Treatment of Paediatric Lymphatic Malformations
Protara Therapeutics has introduced TARA-002 for the treatment of paediatric patients with macrocystic and mixed cystic lymphatic malformations (LMs), a rare congenital disorder....
Immix Biopharma Introduces Breakthrough NXC-201 for the Treatment of Relapsed/Refractory AL Amyloidosis
Immix Biopharma has introduced NXC-201 for the treatment of relapsed/refractory AL amyloidosis, a serious and progressive disorder....
Ipsen Introduces Breakthrough IPN60340 (ICT01) for the Treatment of Acute Myeloid Leukaemia
Ipsen has introduced IPN60340 in combination with venetoclax and azacitidine (Ven-Aza) for the treatment of newly diagnosed acute myeloid leukaemia (AML) in patients considered unfit for intensive chemotherapy....
Altimmune Introduces Breakthrough Pemvidutide for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis
Altimmune has introduced pemvidutide for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other metabolic liver diseases....
Ionis Pharmaceuticals Introduces Breakthrough ION582 for the Treatment of Angelman Syndrome
Ionis Pharmaceuticals has introduced ION582 as an investigational therapy that has received FDA Breakthrough Therapy Designation for the treatment of Angelman syndrome (AS), a rare neurological disorder....
Spruce Biosciences Introduces Breakthrough TA-ERT for the Treatment of Sanfilippo Syndrome Type B
Spruce Biosciences has introduced Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) as an investigational therapy that has received FDA Breakthrough Therapy Designation for the treatment of Sanfilippo Syndrome Type B (MPS IIIB)...
Daiichi Sankyo and Merck Introduce Breakthrough Raludotatug Deruxtecan for the Treatment of Ovarian Cancer
Daiichi Sankyo and Merck have introduced Raludotatug Deruxtecan (R-DXd) as an investigational therapy that has received FDA Breakthrough Therapy Designation for the treatment of adult patients with platinum-resistant ovarian, primary peritoneal,...
